Click for best price

PCR NGSBased Molecular Diagnostics Market Size, Share 2023

Market Analysis and Insights: Global PCR NGSBased Molecular Diagnostics Market

The global PCR NGSBased Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PCR NGSBased Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PCR NGSBased Molecular Diagnostics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PCR NGSBased Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PCR NGSBased Molecular Diagnostics market.

Global PCR NGSBased Molecular Diagnostics Scope and Market Size

PCR and NGS-Based Molecular Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global PCR and NGS-Based Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2032.

Segment by Type

Biomarker Discovery

Blood Sample Testig

Others

Segment by Application

Hospitals

Academics/Research Institutions

Others

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Thermofisher

Illumine

Paragon Genomics

Roche

Qiagen

Bioo Scientific

Agilent

Pillar Biosciences

LC-Bio Technologies (Hangzhou) CO. LTD.

iGen Technologies

Burning Rock

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes PCR NGSBased Molecular Diagnostics product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of PCR NGSBased Molecular Diagnostics, with price, sales, revenue, and global market share of PCR NGSBased Molecular Diagnostics from 2019 to 2022.

Chapter 3, the PCR NGSBased Molecular Diagnostics competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the PCR NGSBased Molecular Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the PCR NGSBased Molecular Diagnostics market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of PCR NGSBased Molecular Diagnostics.

Chapter 13, 14, and 15, to describe PCR NGSBased Molecular Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 PCR NGSBased Molecular Diagnostics Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global PCR and NGS-Based Molecular Diagnostics Market Research Report 2023
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2022
Forecast Year	2030
Number of Pages	91 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Biomarker Discovery
1.2.3 Blood Sample Testig
1.2.4 Others
1.3 Market by Application
1.3.1 Global PCR and NGS-Based Molecular Diagnostics Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Hospitals
1.3.3 Academics/Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PCR and NGS-Based Molecular Diagnostics Market Perspective (2018-2032)
2.2 PCR and NGS-Based Molecular Diagnostics Growth Trends by Region
2.2.1 PCR and NGS-Based Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 PCR and NGS-Based Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Region (2023-2032)
2.3 PCR and NGS-Based Molecular Diagnostics Market Dynamics
2.3.1 PCR and NGS-Based Molecular Diagnostics Industry Trends
2.3.2 PCR and NGS-Based Molecular Diagnostics Market Drivers
2.3.3 PCR and NGS-Based Molecular Diagnostics Market Challenges
2.3.4 PCR and NGS-Based Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue
3.1.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue (2018-2023)
3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global PCR and NGS-Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PCR and NGS-Based Molecular Diagnostics Revenue
3.4 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio
3.4.1 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR and NGS-Based Molecular Diagnostics Revenue in 2022
3.5 PCR and NGS-Based Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Type
4.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2023-2032)
5 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application
5.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America PCR and NGS-Based Molecular Diagnostics Market Size (2018-2032)
6.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
6.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size (2018-2032)
7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size (2018-2032)
8.2 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
8.3 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America PCR and NGS-Based Molecular Diagnostics Market Size (2018-2032)
9.2 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
9.3 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size (2018-2032)
10.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
10.3 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Thermofisher
11.1.1 Thermofisher Company Detail
11.1.2 Thermofisher Business Overview
11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Introduction
11.1.4 Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.1.5 Thermofisher Recent Development
11.2 Illumine
11.2.1 Illumine Company Detail
11.2.2 Illumine Business Overview
11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Introduction
11.2.4 Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.2.5 Illumine Recent Development
11.3 Paragon Genomics
11.3.1 Paragon Genomics Company Detail
11.3.2 Paragon Genomics Business Overview
11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Introduction
11.3.4 Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.3.5 Paragon Genomics Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Introduction
11.4.4 Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Introduction
11.5.4 Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.5.5 Qiagen Recent Development
11.6 Bioo Scientific
11.6.1 Bioo Scientific Company Detail
11.6.2 Bioo Scientific Business Overview
11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Introduction
11.6.4 Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.6.5 Bioo Scientific Recent Development
11.7 Agilent
11.7.1 Agilent Company Detail
11.7.2 Agilent Business Overview
11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Introduction
11.7.4 Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.7.5 Agilent Recent Development
11.8 Pillar Biosciences
11.8.1 Pillar Biosciences Company Detail
11.8.2 Pillar Biosciences Business Overview
11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Introduction
11.8.4 Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.8.5 Pillar Biosciences Recent Development
11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Detail
11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Introduction
11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
11.10 iGen Technologies
11.10.1 iGen Technologies Company Detail
11.10.2 iGen Technologies Business Overview
11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Introduction
11.10.4 iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.10.5 iGen Technologies Recent Development
11.11 Burning Rock
11.11.1 Burning Rock Company Detail
11.11.2 Burning Rock Business Overview
11.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Introduction
11.11.4 Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.11.5 Burning Rock Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Biomarker Discovery
Table 3. Key Players of Blood Sample Testig
Table 4. Key Players of Others
Table 5. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 6. Global PCR and NGS-Based Molecular Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 7. Global PCR and NGS-Based Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region (2018-2023)
Table 9. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 10. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region (2023-2032)
Table 11. PCR and NGS-Based Molecular Diagnostics Market Trends
Table 12. PCR and NGS-Based Molecular Diagnostics Market Drivers
Table 13. PCR and NGS-Based Molecular Diagnostics Market Challenges
Table 14. PCR and NGS-Based Molecular Diagnostics Market Restraints
Table 15. Global PCR and NGS-Based Molecular Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global PCR and NGS-Based Molecular Diagnostics Market Share by Players (2018-2023)
Table 17. Global Top PCR and NGS-Based Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2022)
Table 18. Ranking of Global Top PCR and NGS-Based Molecular Diagnostics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
Table 22. Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global PCR and NGS-Based Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 26. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 27. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2023-2032)
Table 28. Global PCR and NGS-Based Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application (2018-2023)
Table 30. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 31. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application (2023-2032)
Table 32. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032) & (US$ Million)
Table 34. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032) & (US$ Million)
Table 36. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 37. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2023-2032) & (US$ Million)
Table 38. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032) & (US$ Million)
Table 40. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032) & (US$ Million)
Table 42. Thermofisher Company Detail
Table 43. Thermofisher Business Overview
Table 44. Thermofisher PCR and NGS-Based Molecular Diagnostics Product
Table 45. Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 46. Thermofisher Recent Development
Table 47. Illumine Company Detail
Table 48. Illumine Business Overview
Table 49. Illumine PCR and NGS-Based Molecular Diagnostics Product
Table 50. Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 51. Illumine Recent Development
Table 52. Paragon Genomics Company Detail
Table 53. Paragon Genomics Business Overview
Table 54. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product
Table 55. Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 56. Paragon Genomics Recent Development
Table 57. Roche Company Detail
Table 58. Roche Business Overview
Table 59. Roche PCR and NGS-Based Molecular Diagnostics Product
Table 60. Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 61. Roche Recent Development
Table 62. Qiagen Company Detail
Table 63. Qiagen Business Overview
Table 64. Qiagen PCR and NGS-Based Molecular Diagnostics Product
Table 65. Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 66. Qiagen Recent Development
Table 67. Bioo Scientific Company Detail
Table 68. Bioo Scientific Business Overview
Table 69. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product
Table 70. Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 71. Bioo Scientific Recent Development
Table 72. Agilent Company Detail
Table 73. Agilent Business Overview
Table 74. Agilent PCR and NGS-Based Molecular Diagnostics Product
Table 75. Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 76. Agilent Recent Development
Table 77. Pillar Biosciences Company Detail
Table 78. Pillar Biosciences Business Overview
Table 79. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product
Table 80. Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 81. Pillar Biosciences Recent Development
Table 82. LC-Bio Technologies (Hangzhou) CO. LTD. Company Detail
Table 83. LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
Table 84. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product
Table 85. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 86. LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
Table 87. iGen Technologies Company Detail
Table 88. iGen Technologies Business Overview
Table 89. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product
Table 90. iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 91. iGen Technologies Recent Development
Table 92. Burning Rock Company Detail
Table 93. Burning Rock Business Overview
Table 94. Burning Rock PCR and NGS-Based Molecular DiagnosticsProduct
Table 95. Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 96. Burning Rock Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PCR and NGS-Based Molecular Diagnostics Market Share by Type: 2022 VS 2032
Figure 2. Biomarker Discovery Features
Figure 3. Blood Sample Testig Features
Figure 4. Others Features
Figure 5. Global PCR and NGS-Based Molecular Diagnostics Market Share by Application in 2022 & 2032
Figure 6. Hospitals Case Studies
Figure 7. Academics/Research Institutions Case Studies
Figure 8. Others Case Studies
Figure 9. PCR and NGS-Based Molecular Diagnostics Report Years Considered
Figure 10. Global PCR and NGS-Based Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 11. Global PCR and NGS-Based Molecular Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 12. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region: 2022 VS 2032
Figure 13. Global PCR and NGS-Based Molecular Diagnostics Market Share by Players in 2022
Figure 14. Global Top PCR and NGS-Based Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue in 2022
Figure 16. North America PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 17. North America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2018-2032)
Figure 18. United States PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 19. Canada PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. Europe PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 21. Europe PCR and NGS-Based Molecular Diagnostics Market Share by Country (2018-2032)
Figure 22. Germany PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. France PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. U.K. PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. Italy PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. Russia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Nordic Countries PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Share by Region (2018-2032)
Figure 30. China PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. Japan PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. South Korea PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. India PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. Australia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Latin America PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2018-2032)
Figure 38. Mexico PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Brazil PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 41. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Share by Country (2018-2032)
Figure 42. Turkey PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Saudi Arabia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 44. Thermofisher Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 45. Illumine Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 46. Paragon Genomics Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 47. Roche Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 48. Qiagen Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 49. Bioo Scientific Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 50. Agilent Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 51. Pillar Biosciences Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 52. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 53. iGen Technologies Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 54. Burning Rock Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $2762

Multi User Price : $4143

Enterprise Price : $5524

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global PCR and NGS-Based Molecular Diagnostics Market Research Report 2023